Tapentadol Hcl
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB06204 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 45 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | migraine disorder | KG + DL |
| 2 | migraine with brainstem aura | KG + DL |
| 3 | migraine with or without aura, susceptibility to | KG + DL |
| 4 | atrophoderma vermiculata | KG + DL |
| 5 | ulerythema ophryogenesis | KG + DL |
| 6 | insomnia (disease) | KG + DL |
| 7 | headache disorder | KG + DL |
| 8 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 9 | trigeminal autonomic cephalalgia | KG + DL |
| 10 | anxiety | KG + DL |
| 11 | sciatic neuropathy | KG + DL |
| 12 | common cold | KG + DL |
| 13 | dysthymic disorder | KG + DL |
| 14 | irritable bowel syndrome | KG + DL |
| 15 | neurocirculatory asthenia | KG + DL |
| 16 | anxiety disorder | KG + DL |
| 17 | tendinitis | KG + DL |
| 18 | myositis fibrosa | KG + DL |
| 19 | idiopathic granulomatous myositis | KG + DL |
| 20 | fibromyalgia | KG + DL |
| 21 | agoraphobia | KG + DL |
| 22 | benign paroxysmal torticollis of infancy | KG + DL |
| 23 | inclusion body myositis | KG + DL |
| 24 | autonomic nervous system disease | KG + DL |
| 25 | open-angle glaucoma | KG + DL |
| 26 | glossodynia | KG + DL |
| 27 | coccygodynia | KG + DL |
| 28 | primary hereditary glaucoma | KG + DL |
| 29 | bronchial disease | KG + DL |
| 30 | pulmonary hypertension | KG + DL |
| 31 | rhinitis | KG + DL |
| 32 | cauda equina syndrome | KG + DL |
| 33 | allergic urticaria | KG + DL |
| 34 | kyphoscoliotic heart disease | KG + DL |
| 35 | cluster headache syndrome | KG + DL |
| 36 | peripheral vascular disease | KG + DL |
| 37 | respiratory failure | KG + DL |
| 38 | endobronchial leiomyoma | KG + DL |
| 39 | myofascial pain syndrome | KG + DL |
| 40 | restless legs syndrome | KG + DL |
| 41 | endobronchial lipoma | KG + DL |
| 42 | sleep disorder, initiating and maintaining sleep | KG + DL |
| 43 | bronchus adenoma | KG + DL |
| 44 | Tourette syndrome | KG + DL |
| 45 | Ambras type hypertrichosis universalis congenita | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.